Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05228444
Other study ID # 150949
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date October 28, 2020
Est. completion date January 28, 2023

Study information

Verified date November 2022
Source University Hospital Padova
Contact Sara Montagnese
Phone +390498218675
Email sara.montagnese@unipd.it
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Sleep is regulated by the interaction of homeostatic and circadian processes. The homeostatic process determines sleep propensity in relation to sleep-wake history, the circadian one is responsible for the alternation of high/low sleep propensity in relation to dark/light cues, and is substantially independent of preceding sleep-wake behaviour. The circadian timing system encompasses a master clock in the brain and peripheral, ancillary time-keepers in virtually every organ of the body. In recent years, evidence has emerged that circadian disruption has serious medical consequences, including sleep loss, increased cardiovascular morbidity and increased risk of certain types of cancer. Evidence is also emerging that hospitalization per se weakens circadian rhythmicity, due to disease itself and to modified light, food and activity cues. The aim of our project is to test an inpatient management system (CircadianCare) that limits the circadian impact of hospitalisation by enhancing circadian rhythmicity through an assessment of the patient's specific circadian features/needs and an ad hoc, personalized light-dark, meal and activity schedule to cover the whole of the inpatient stay. This will be compared to standard inpatient management in terms of patients' perception, sleep-wake quality and timing during hospitalisation, inpatient utilization of sleep-inducing medication, length of hospitalisation, and prognosis (i.e. outcome of hospitalisation, subsequent hospitalisations and post-discharge sleep-wake disturbances). The CircadianCare system is expected to benefit prognosis, decrease costs, and change the way hospitals are organized and designed in future, with potential direct relevance to the plans for the new University Hospital of Padova.


Recruitment information / eligibility

Status Recruiting
Enrollment 50
Est. completion date January 28, 2023
Est. primary completion date January 28, 2023
Accepts healthy volunteers No
Gender All
Age group N/A and older
Eligibility Inclusion Criteria: • Hospitalized patients Exclusion Criteria: • absence of compliance

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
CircadianCare
enhancing circadian rhythmicity through an assessment of the patient's specific circadian features/needs and an ad hoc, personalized light-dark, meal and activity schedule to cover the whole of the inpatient stay.

Locations

Country Name City State
Italy Padova University Hospital Padova

Sponsors (1)

Lead Sponsor Collaborator
University Hospital Padova

Country where clinical trial is conducted

Italy, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in sleep onset latency - actigraphy Sleep latency (number of minutes between try to sleep and sleep onset, SL) is objectively assessed by wrist actigraphy device. SL > 30 min is considered clinically significant. (scale minutes) first, 7th and 14 day
Primary Change in sleep onset latency - sleep diary The number of minutes between try to sleep and sleep onset as measured by sleep diary. Sleep latency > 30 min is considered clinically significant. (scale minutes) first, 7th and 14 day
Primary Change in sleep duration - actigraphy Total sleep time (TST) is calculated as hours per night spent sleeping while in bed after light off. It is objectively assessed by wrist actigraphy device. (scale hours) first, 7th and 14 day
Primary Change in sleep duration - sleep diary Total sleep time (TST) is calculated as hours per night spent sleeping while in bed after light off. It is assessed using daily sleep diaries. (scale hours) first, 7th and 14 day
Primary Change in sleep awakening - actigraphy Measured with wrist actigraphy, wake after sleep onset (WASO) is the number of minutes scored as wake from sleep onset until the end of the last sleep episode while in bed. (scale minutes) first, 7th and 14 day
Primary Change in sleep awakening - sleep diary Measured with sleep diary. Wake after sleep onset (WASO) is a subjective measure of participants' sleeping and waking times in which time awake expressed in minutes after sleep onset is obtained. first, 7th and 14 day
Primary Change in sleep efficiency - actigraphy Measured with wrist actigraphy, sleep efficiency (SE) is the percentage of time (0%-100%) the participant was sleeping from sleep onset (defined as the first 20 continuous minutes of sleep after getting into bed) until the last minute scored as sleep (the following morning). first, 7th and 14 day
Primary Change in sleep efficiency - sleep diary Measured with sleep diary. The sleep efficiency is a subjective measure of participants' sleeping and waking times, from which sleep efficiency is computed as the quota between time sleeping/time spent in bed, expressed in percentage. first, 7th and 14 day
Primary Actigraphy - change in fragmentation of activity-rest periods Interdaily variability (IV) quantifies the degree of fragmentation. The variable has a theoretical range of 0 to 2 with higher values indicating higher fragmentation. Typical values for healthy subjects will be below 1. 14 days
Primary Actigraphy - change in sleep regularity over days Intradaily stability (IS) quantifies the degree of regularity in the activity-rest pattern with a range of 0 to 1 where a value of 0 indicates a total lack of rhythm and a value of 1 indicates a perfectly stable rhythm. 14 days
Primary Change in daytime sleepiness Karolinska Sleepiness Scale (KSS) comprises a single item assessing state sleepiness at a particular time (every hour) during the day on a scale from 1 (very rested) to 9 (very sleepy). first day then again at 7th and 14th day
Primary Salivary melatonin shift A change in the timing of the circadian system is measured using the Dim Light Melatonin Onset (DLMO), gold standard for measuring human circadian phase. Salivary melatonin is measured five times every 1h before usual bedtime and assayed using standard commercially-available radioimmunoassay (RIA) kits. The time at which melatonin rises above a 4 pg/mL threshold is the DLMO. baseline DLMO and then again at 7th and 14th day
Primary Diurnal preference Short version Munich Chronotype Questionnaire (microMCTQ), measure chronotype based on the midpoint of sleep. first day
Primary Assess circadian preference Morning-evening questionnaire (MEQ) scale: MEQ sum score, range: 16-86, participants are classified as Morning-types (scores between 59 and 86), Neither-types (scores between 42 and 58), and Evening-types (scores between 16 and 41). first day
Primary Sleep quality Pittsburgh Sleep Quality Index (PSQI) scale: global PSQI score, range: 0 - 21, scores of 5 or higher indicate poor sleep quality. first day
Secondary Monitoring environment temperature Temperature levels within ward rooms will be monitored at regular intervals by ibutton temperature sensors, using the Celsius scale. first, 7th 14th day
Secondary Monitoring environment noise Noise levels within ward rooms will be monitored at regular intervals by phonometers. Noise level is measured in decibels (dB) first, 7th 14th day
See also
  Status Clinical Trial Phase
Recruiting NCT04578249 - Effects of Blocking Blue Light at Night Post CABG, AVR, MVR, CABG AVR, CABG MVR, or SAH N/A
Recruiting NCT06129942 - Light Therapy in Parkinson's Disease N/A
Recruiting NCT06083831 - The Effect of Sequential Feeding for Circadian Rhythm and Gut Flora Rhythm in Critically Ill Patients
Active, not recruiting NCT04953754 - Melatonin and Vaccine Response, Immunity, and Chronobiology Study N/A
Not yet recruiting NCT05452096 - SHIFTPLAN: an RCT Investigating the Effect of a Shift Work Intervention on Fatigue, Sleep and Health. N/A
Completed NCT01327040 - Light Sensitization Study N/A
Completed NCT03331822 - The Effects of Bright Light Exposure on ICU Nurses N/A
Completed NCT03646084 - Sleep and Circadian Intervention Program for Chronic Musculoskeletal Pain N/A
Recruiting NCT04690504 - Validation of Circadian Biomarkers in Patients With Sleep Disorders
Recruiting NCT06023654 - Identifying Circadian Rest-Activity Rhythm Disorders in Patients With Advanced Cancer
Completed NCT03682185 - The Healthy Patterns Sleep Study Phase 3
Recruiting NCT06346613 - Prevalence and Affecting Factors of Sleep and Circadian Rhythm Disorders in ICU
Recruiting NCT05309577 - Self-Care for Dementia Caregivers N/A
Completed NCT04157244 - The Music, Sleep and Dementia Study N/A
Completed NCT03468400 - Evaluation of the Reliability and Validity of a Diagnostic Sleep Disorders Questionnaire
Recruiting NCT04063332 - Functionality of Endogenous Biological Clock in Sepsis
Recruiting NCT06329479 - A Feasibility Trial for Circadian Rest-activity Rhythm Disorders in Cancer (RALI) N/A
Recruiting NCT04401189 - The Role of Circadian Rhythms in Cancer-Related Symptoms
Completed NCT03684460 - Daytime Bright Light, Circadian Abnormalities, and Delirium in Medical ICU Patients N/A
Terminated NCT03141086 - A Study to Assess the Wakefulness Promoting Effect, Safety, Tolerability, and Pharmacokinetics (PK) of LML134 in Shift Work Disorder Phase 2